| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(4 months ago) | |
|
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(a month from now) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(11 months from now) | |
| US9987229 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(11 months from now) | |
|
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(1 year, 5 months from now) | |
|
US9987229 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(1 year, 5 months from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 7 months from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 7 months from now) | |
|
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(2 years from now) | |
|
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(2 years from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(4 years from now) | |
|
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(4 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(7 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(7 years from now) | |
|
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(7 years from now) | |
|
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(8 years from now) | |
|
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(8 years from now) | |
|
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(8 years from now) | |
|
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(8 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(8 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(8 years from now) | |
|
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(8 years from now) | |
|
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(8 years from now) | |
|
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(8 years from now) | |
| US9415008 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(11 years from now) | |
| US9066957 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(11 years from now) | |
|
US9415008 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(11 years from now) | |
|
US9066957 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(11 years from now) | |
| US9782550 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| US9782551 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(12 years from now) | |
|
US9782551 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(12 years from now) | |
|
US9782550 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(12 years from now) | |
|
US10918816 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Jun, 2036
(12 years from now) | |
| US10569034 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(12 years from now) | |
|
US10569034 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2037
(13 years from now) | |
| US11351317 | TEVA PHARM | Drug delivery device with electronics |
Feb, 2038
(14 years from now) | |
|
US11351317 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Aug, 2038
(14 years from now) | |
| US11357935 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2038
(14 years from now) | |
| US11000653 | TEVA PHARM | Inhaler |
Dec, 2038
(15 years from now) | |
|
US11000653 (Pediatric) | TEVA PHARM | Inhaler |
Jun, 2039
(15 years from now) | |
| US11344685 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2039
(16 years from now) | |
|
US11344685 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2040
(16 years from now) | |
| US11439777 | TEVA PHARM | Drug delivery device with electronics |
May, 2040
(16 years from now) | |
| US11464923 | TEVA PHARM | Inhaler system |
Jun, 2040
(16 years from now) | |
| US11173259 | TEVA PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(16 years from now) | |
|
US11173259 (Pediatric) | TEVA PHARM | Drug delivery device with electronics and power management |
Jan, 2041
(17 years from now) | |
| US11266796 | TEVA PHARM | Inhalation device with integrated electronics |
Feb, 2041
(17 years from now) | |
|
US11266796 (Pediatric) | TEVA PHARM | Inhalation device with integrated electronics |
Aug, 2041
(17 years from now) | |
Airduo Digihaler is owned by Teva Pharm.
Airduo Digihaler contains Fluticasone Propionate; Salmeterol Xinafoate.
Airduo Digihaler has a total of 53 drug patents out of which 1 drug patent has expired.
Expired drug patents of Airduo Digihaler are:
- US7540282
Airduo Digihaler was authorised for market use on 27 January, 2017.
Airduo Digihaler is available in powder;inhalation dosage forms.
Airduo Digihaler can be used as treatment of asthma.
The generics of Airduo Digihaler are possible to be released after 22 August, 2041.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M (M) | Jul 9, 2024 |
| Pediatric Exclusivity (PED) | Jan 9, 2025 |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 27 January, 2017
Treatment: Treatment of asthma
Dosage: POWDER;INHALATION
AIRDUO DIGIHALER family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic